Cargando…
Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
Due to its central role in the cellular biology of prostate cancer (PC), androgen receptor (AR) still remains an important therapeutic target for fighting this tumor. Several drugs targeting AR have been reported so far, and many new molecules are expected for the future. In spite of their antitumor...
Autores principales: | Beretta, Giovanni L., Zaffaroni, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546842/ https://www.ncbi.nlm.nih.gov/pubmed/31192191 http://dx.doi.org/10.3389/fchem.2019.00369 |
Ejemplares similares
-
Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential
por: Beretta, Giovanni Luca, et al.
Publicado: (2022) -
Targeting the Androgen Receptor with Steroid Conjugates: Miniperspective
por: Levine, Paul M., et al.
Publicado: (2014) -
Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012) -
The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014) -
Identification of novel androgen receptor target genes in prostate cancer
por: Jariwala, Unnati, et al.
Publicado: (2007)